drugset
drugset / Trial / NCT01709136

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

NCT01709136 ↗

Phase 2/3 Terminated 3 enrolled University of Pittsburgh
NaSingle-groupOpen-labelTreatment

Summary

Pharmacokinetics of Tacrolimus and Sirolimus alone and in combination in liver transplant recipients.

Timeline

Start
2005-12
Primary completion
2010-01
Completion
2010-01

Outcome

Outcome not reported

Stopped: “Sirolimus usage discontinued since black box warning”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule 2 mg/m2 —

Indications

hypertensive disorder